STOCK TITAN

IRRAS to Present at Redeye

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IRRAS, a global healthcare company specializing in neurocritical care, will present its strategy on March 30, 2021, from 4:00 pm to 5:00 pm CET, at the Swedish Investment Bank Redeye. CEO Kleanthis G. Xanthopoulos and President Will Martin will lead the session, including a presentation followed by a Q&A lasting one hour. A live webcast will be available at this link. More information about the company can be found at www.irras.com. IRRAS is listed on Nasdaq Stockholm under the ticker IRRAS.

Positive
  • None.
Negative
  • None.

STOCKHOLM, March 23, 2021 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at the Swedish Investment Bank Redeye on March 30 at 4:00 pm-5:00pm CET.

Kleanthis G. Xanthopoulos, Ph.D., CEO and Will Martin, President and CCO will present the IRRAS strategy and answer follow up questions. In total the presentation and the Q&A session is estimated to take one hour.

A link with an invitation which will be webcast live is presented below.

https://www.redeye.se/events/806966/strategy-update-irras

The presentation will also be made available on www.irras.com.

About IRRAS

IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners.  

IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA. For more information, please visit www.irras.com

IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker: IRRAS).

For more information, please contact:

USA

Kleanthis G. Xanthopoulos, Ph.D.
CEO
ir@irras.com   

Europe

Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com 

The information was released for public disclosure, through the agency of the contact person above, on March 23, 2021 at 08:00 (CET).

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/irras/r/irras-to-present-at-redeye,c3311974

Cision View original content:http://www.prnewswire.com/news-releases/irras-to-present-at-redeye-301253479.html

SOURCE IRRAS

FAQ

When will IRRAS present at Redeye?

IRRAS will present on March 30, 2021, from 4:00 pm to 5:00 pm CET.

Who are the presenters for IRRAS at Redeye?

The presenters will be CEO Kleanthis G. Xanthopoulos and President Will Martin.

How long is the IRRAS presentation expected to last?

The presentation and Q&A session are estimated to last one hour.

Where can I watch the IRRAS presentation?

The presentation will be webcast live at the Redeye event link.

What is IRRAS known for?

IRRAS is known for its innovative products in neurocritical care, improving patient outcomes and reducing care costs.

What is the stock symbol for IRRAS?

IRRAS is listed on Nasdaq Stockholm with the ticker symbol IRRAS.

IRRAS AB

OTC:IRRAF

IRRAF Rankings

IRRAF Latest News

IRRAF Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Stockholm